Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||
| Net Income | -5,572 | -22,100 |
| Depreciation Amortization | 71 | 340 |
| Accounts receivable | 161 | N/A |
| Accounts payable and accrued liabilities | 1,060 | N/A |
| Other Working Capital | 826 | 260 |
| Other Operating Activity | -1,148 | 500 |
| Operating Cash Flow | $-4,602 | $-21,000 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -2 | -180 |
| Investing Cash Flow | $-2 | $-180 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -748 | N/A |
| Common Stock Issued | 16 | N/A |
| Other Financing Activity | 0 | 22,540 |
| Financing Cash Flow | $-732 | $22,540 |
| Beginning Cash Position | 16,707 | 15,340 |
| End Cash Position | 11,371 | 16,700 |
| Net Cash Flow | $-5,336 | $1,360 |
| Free Cash Flow | ||
| Operating Cash Flow | -4,602 | -21,000 |
| Capital Expenditure | -2 | N/A |
| Free Cash Flow | -4,604 | -21,000 |